dizziness from tirzepatide Is a Side Effect of Mounjaro? Understanding the Implications and Management Strategies – PlexusDx The Story of Mounjaro (Tirzepatide)

P20-30-150-115) and the mixture was moderately agitated after NMP was added

Since weight loss is a major therapeutic goal, patients should record weekly measurements

Underwriters are also getting better at detecting GLP-1 use through: Prescription databases Medical records requests Follow-up health questionnaires What This Means for Your Clients If currently on GLP-1 medications: Expect questions about medication use and duration Be prepared for potentially higher rates despite current health improvements Consider timing of application if they've been stable on medication for an extended period If recently stopped GLP-1 medications: Underwriters may view recent discontinuation as a risk factor Weight regain could further complicate the application process Medical follow-up showing sustained health improvements may help If planning to start GLP-1 medications: Understand that future applications may be affected by medication use Industry Trends to Watch Some forward-thinking insurance companies are exploring partnerships with GLP-1 providers to improve medication adherence

New research has explored the potential of FMT as a promising approach for addressing cardiometabolic disorders (257)